What You Should Know:
– Syapse, a real-world evidence company is teaming up with Pierian®, a provider of advanced clinical genomics technology on a new joint collaboration that will benefit patients of the AdventHealth Cancer Institute in Central Florida.
– The collaboration combines Syapse’s real-world evidence solutions designed to improve outcomes for patients with cancer, Pierian’s leading-edge clinical genomics workflow, and precision medicine services that provide the most relevant insights in the industry.
Comprehensive Diagnostics for Oncology Patients in Central Florida
This partnership will enable AdventHealth clinicians to offer more comprehensive diagnostics for oncology patients in Central Florida, allowing more personalized treatment options due to improved capabilities to identify known and emerging biomarkers critical for cancer treatment and progression. It will also enable more efficient identification of clinical trials and treatment options for patients based on their molecular testing results and similar patients in the Syapse Learning Health Network (LHN). Syapse and Pierian will collaborate on optimizing AdventHealth’s internal genomic testing capabilities for all patients who may benefit to improve the actionable insights gathered from test orders and genomic results allowing a deeper understanding of the relationship between these insights and real patient outcomes.